Company page

Neurogenesis

Neurogenesis (ticker: NEUN) is a public company operating in the American market, with a market capitalization of approximately $8.23 billion. The company focuses on advancements in neurobiology and related technologies. Neurogenesis aims to develop innovative solutions to improve brain health and cognitive function.